oxidopamine hydrochloride has been researched along with 4-nonylphenol in 1 studies
*4-nonylphenol: structure in first source; see also record for nonylphenol [MeSH]
*4-nonylphenol: structure in first source; see also record for nonylphenol [MeSH]
| Studies (oxidopamine hydrochloride) | Trials (oxidopamine hydrochloride) | Recent Studies (post-2010) (oxidopamine hydrochloride) | Studies (4-nonylphenol) | Trials (4-nonylphenol) | Recent Studies (post-2010) (4-nonylphenol) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 605 | 0 | 316 |
| Protein | Taxonomy | oxidopamine hydrochloride (IC50) | 4-nonylphenol (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.571 | |
| Estrogen receptor | Homo sapiens (human) | 0.377 | |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 0.35 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.254 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 6.78 | |
| Adenosine receptor A3 | Homo sapiens (human) | 1.915 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 9.5 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 4.19 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.915 | |
| Substance-K receptor | Homo sapiens (human) | 4.514 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.254 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.571 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 3.38 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.915 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 9.5 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.649 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for oxidopamine hydrochloride and 4-nonylphenol
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |